Drug intelligence / Profile preview

Actoferrin

Development stage
Preclinical
Lead developer
Bennet Pharmaceuticals
Modality
Recombinant Proteins and Enzymes
Administration
Oral
01

Overview

Actoferrin is a patented oral tablet formulation of lactoferrin (100 mg) developed by Bennet Pharmaceuticals. The product utilizes proprietary SALT (Solid Absorption and Lipid Technology) to enhance the bioavailability of lactoferrin, a multifunctional iron-binding glycoprotein naturally found in milk and other secretions. Lactoferrin exhibits antimicrobial, antiviral, anti-inflammatory, and immunomodulatory properties, primarily by sequestering iron required for microbial growth and interacting with immune cell receptors to modulate inflammatory responses. While specific clinical trial phases for this formulation are not publicly detailed, it is positioned for therapeutic use in managing infections and supporting immune health.

Brand names
Actoferrin
Other names
Lactoferrin 100 mg tabletsLactoferrin100 mg tabletsLactoferrin-100 mg tabletsActoferrin (SALT technology formulation)
02

Targets

LbpAB (Lactoferrin receptor complex LbpA/LbpB)OmpC (Outer membrane porin C)LTF (Lactoferrin)ITLN1 (Intelectin-1)PhoE (Outer membrane porin PhoE)

Beyond the preview

Go deeper on Actoferrin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Actoferrin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call